School of Chemistry, University of Birmingham
Mercachem is a Dutch-based chemistry CRO, offering chemistry challenge solving services through the following areas, ranging from small-scale screening to kilogram-scale GMP production:chemistry challenge solving services through the following areas, ranging from small scale screening to kilogram-scale GMP production:
- Discovery chemistry (natural products, reference compounds, metabolites etc.)
- Medicinal chemistry (drug design with specialization in (neuro) kinases, PPI and epigenetics) including hit-generation services (DNA-encoded libraries and Fragment-based drug discovery) and several ‘kick-start’ projects open for partnering.
- Parallel synthesis (Hit confirmation libraries, Hit-to-lead libraries, target family-centric libraries, etc.)
- Process research services (route scouting, catalyst screening, scale-up, production of tox-batches etc.), including cGMP production of API for clinical trials.
With the cumulative brain power of >150 chemists, combined with our transparent culture and professional mind, Mercachem is regarded as one of the most reliable chemistry partners in the industry.
AnalytiCon Discovery is all about natural products. In the course of evolution, these molecules have been optimized to display a wide range of biological effects. AnalytiCon is exploiting the opportunity inherent in these small-molecule compounds. As a research and development company, we are a globally preferred partner to companies in the pharmaceutical, cosmetic, food and agrisciences sectors. We cover the entire spectrum from establishing compound libraries, identifying active ingredients and synthetically optimizing them to production on a commercial scale.
ApconiX is a team of world-renowned nonclinical safety experts with over 300 years of drug discovery and development expertise. We work with our partners to provide the advice they need, at the right time to make better decisions on drug safety, from project initiation through to worldwide marketing approval. ApconiX is a team of experienced scientists covering all major safety disciplines, with our own ion channel laboratory and a commitment to advancing the science of drug safety.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 765116.